Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Climb Bio (CLYM) Cash from Operations (2020 - 2026)

Climb Bio filings provide 7 years of Cash from Operations readings, the most recent being 14379000.0 for Q1 2026.

  • Quarterly Cash from Operations rose 6.84% to 14379000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 53301000.0 through Mar 2026, down 82.68% year-over-year, with the annual reading at 54356000.0 for FY2025, 249.29% down from the prior year.
  • Cash from Operations hit 14379000.0 in Q1 2026 for Climb Bio, up from 15635000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 3490000.0 in Q3 2023 and bottomed at 15635000.0 in Q4 2025.
  • Average Cash from Operations over 5 years is 8368529.41, with a median of 8449000.0 recorded in 2022.
  • The largest annual shift saw Cash from Operations surged 183.59% in 2023 before it tumbled 1571.36% in 2025.
  • Climb Bio's Cash from Operations stood at 8449000.0 in 2022, then surged by 88.79% to 947000.0 in 2023, then tumbled by 483.0% to 5521000.0 in 2024, then plummeted by 183.19% to 15635000.0 in 2025, then rose by 8.03% to 14379000.0 in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Cash from Operations are 14379000.0 (Q1 2026), 15635000.0 (Q4 2025), and 12139000.0 (Q3 2025).